APO Research

APO RESEARCH · REPORT

Wearable Neuromodulation Devices

Selected research

Industry Research

Wearable Neuromodulation Devices Industry Research Report 2026

Market perspective

The global Wearable Neuromodulation Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Wearable Neuromodulation Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Wearable Neuromodulation Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Wearable Neuromodulation Devices include Brainco, NeuroSky, Muse, Halo Neuroscience, Caputron, Nerivio, Magnus, Emotiv and Thync, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Wearable Neuromodulation Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Wearable Neuromodulation Devices Market by Company

Brainco

NeuroSky

Muse

Halo Neuroscience

Caputron

Nerivio

Magnus

Emotiv

Thync

Wearable Neuromodulation Devices Segment by Type

Head-mounted

Ear-mounted

Arm-mounted

Others

Wearable Neuromodulation Devices Segment by Application

Adults

Children

Wearable Neuromodulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Neuromodulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Neuromodulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Neuromodulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Wearable Neuromodulation Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Wearable Neuromodulation Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Wearable Neuromodulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Wearable Neuromodulation Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Wearable Neuromodulation Devices Sales (k units) of Manufacturers (2021-2026) Table 7. Global Wearable Neuromodulation Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Wearable Neuromodulation Devices Revenue of Manufacturers (2021-2026) Table 9. Global Wearable Neuromodulation Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Wearable Neuromodulation Devices Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Wearable Neuromodulation Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Wearable Neuromodulation Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Wearable Neuromodulation Devices, Product Type & Application Table 14. Global Wearable Neuromodulation Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Wearable Neuromodulation Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Brainco Company Information Table 19. Brainco Business Overview Table 20. Brainco Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Brainco Wearable Neuromodulation Devices Product Portfolio Table 22. Brainco Recent Developments Table 23. NeuroSky Company Information Table 24. NeuroSky Business Overview Table 25. NeuroSky Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. NeuroSky Wearable Neuromodulation Devices Product Portfolio Table 27. NeuroSky Recent Developments Table 28. Muse Company Information Table 29. Muse Business Overview Table 30. Muse Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Muse Wearable Neuromodulation Devices Product Portfolio Table 32. Muse Recent Developments Table 33. Halo Neuroscience Company Information Table 34. Halo Neuroscience Business Overview Table 35. Halo Neuroscience Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio Table 37. Halo Neuroscience Recent Developments Table 38. Caputron Company Information Table 39. Caputron Business Overview Table 40. Caputron Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Caputron Wearable Neuromodulation Devices Product Portfolio Table 42. Caputron Recent Developments Table 43. Nerivio Company Information Table 44. Nerivio Business Overview Table 45. Nerivio Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Nerivio Wearable Neuromodulation Devices Product Portfolio Table 47. Nerivio Recent Developments Table 48. Magnus Company Information Table 49. Magnus Business Overview Table 50. Magnus Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Magnus Wearable Neuromodulation Devices Product Portfolio Table 52. Magnus Recent Developments Table 53. Emotiv Company Information Table 54. Emotiv Business Overview Table 55. Emotiv Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Emotiv Wearable Neuromodulation Devices Product Portfolio Table 57. Emotiv Recent Developments Table 58. Thync Company Information Table 59. Thync Business Overview Table 60. Thync Wearable Neuromodulation Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Thync Wearable Neuromodulation Devices Product Portfolio Table 62. Thync Recent Developments Table 63. Global Wearable Neuromodulation Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Wearable Neuromodulation Devices Sales by Region (2021-2026) & (k units) Table 65. Global Wearable Neuromodulation Devices Sales Market Share by Region (2021-2026) Table 66. Global Wearable Neuromodulation Devices Sales by Region (2027-2032) & (k units) Table 67. Global Wearable Neuromodulation Devices Sales Market Share by Region (2027-2032) Table 68. Global Wearable Neuromodulation Devices Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Wearable Neuromodulation Devices Revenue Market Share by Region (2021-2026) Table 70. Global Wearable Neuromodulation Devices Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Wearable Neuromodulation Devices Revenue Market Share by Region (2027-2032) Table 72. North America Wearable Neuromodulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 74. North America Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 75. North America Wearable Neuromodulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Wearable Neuromodulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Wearable Neuromodulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 79. Europe Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 80. Europe Wearable Neuromodulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Wearable Neuromodulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Wearable Neuromodulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 84. Asia Pacific Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 85. Asia Pacific Wearable Neuromodulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Wearable Neuromodulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Wearable Neuromodulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 89. South America Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 90. South America Wearable Neuromodulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Wearable Neuromodulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Wearable Neuromodulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 94. Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 95. Middle East and Africa Wearable Neuromodulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Wearable Neuromodulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 98. Global Wearable Neuromodulation Devices Sales by Type (2027-2032) & (k units) Table 99. Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2026) Table 100. Global Wearable Neuromodulation Devices Sales Market Share by Type (2027-2032) Table 101. Global Wearable Neuromodulation Devices Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Wearable Neuromodulation Devices Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2026) Table 104. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2027-2032) Table 105. Global Wearable Neuromodulation Devices Price by Type (2021-2026) & (USD/unit) Table 106. Global Wearable Neuromodulation Devices Price by Type (2027-2032) & (USD/unit) Table 107. Global Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 108. Global Wearable Neuromodulation Devices Sales by Application (2027-2032) & (k units) Table 109. Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2026) Table 110. Global Wearable Neuromodulation Devices Sales Market Share by Application (2027-2032) Table 111. Global Wearable Neuromodulation Devices Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Wearable Neuromodulation Devices Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2026) Table 114. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2027-2032) Table 115. Global Wearable Neuromodulation Devices Price by Application (2021-2026) & (USD/unit) Table 116. Global Wearable Neuromodulation Devices Price by Application (2027-2032) & (USD/unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Wearable Neuromodulation Devices Distributors List Table 120. Wearable Neuromodulation Devices Customers List Table 121. Wearable Neuromodulation Devices Industry Trends Table 122. Wearable Neuromodulation Devices Industry Drivers Table 123. Wearable Neuromodulation Devices Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Wearable Neuromodulation Devices Product Image Figure 5. Global Wearable Neuromodulation Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Wearable Neuromodulation Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Wearable Neuromodulation Devices Sales (2021-2032) & (k units) Figure 8. Global Wearable Neuromodulation Devices Average Price (USD/unit) & (2021-2032) Figure 9. Head-mounted Product Image Figure 10. Ear-mounted Product Image Figure 11. Arm-mounted Product Image Figure 12. Others Product Image Figure 13. Adults Product Image Figure 14. Children Product Image Figure 15. Global Wearable Neuromodulation Devices Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Wearable Neuromodulation Devices, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Wearable Neuromodulation Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Wearable Neuromodulation Devices Sales by Region in 2025 Figure 21. Global Wearable Neuromodulation Devices Revenue by Region in 2025 Figure 22. North America Wearable Neuromodulation Devices Market Size by Country in 2025 Figure 23. North America Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 24. North America Wearable Neuromodulation Devices Revenue Market Share by Country (2021-2032) Figure 25. United States Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Wearable Neuromodulation Devices Market Size by Country in 2025 Figure 29. Europe Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 30. Europe Wearable Neuromodulation Devices Revenue Market Share by Country (2021-2032) Figure 31. Germany Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Wearable Neuromodulation Devices Market Size by Country in 2025 Figure 42. Asia Pacific Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Wearable Neuromodulation Devices Revenue Market Share by Country (2021-2032) Figure 44. China Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Wearable Neuromodulation Devices Market Size by Country in 2025 Figure 53. South America Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 54. South America Wearable Neuromodulation Devices Revenue Market Share by Country (2021-2032) Figure 55. Brazil Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Wearable Neuromodulation Devices Market Size by Country in 2025 Figure 59. Middle East and Africa Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Wearable Neuromodulation Devices Revenue Market Share by Country (2021-2032) Figure 61. Egypt Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Wearable Neuromodulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2032) Figure 67. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2032) Figure 68. Global Wearable Neuromodulation Devices Price (USD/unit) by Type (2021-2032) Figure 69. Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2032) Figure 70. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2032) Figure 71. Global Wearable Neuromodulation Devices Price (USD/unit) by Application (2021-2032) Figure 72. Wearable Neuromodulation Devices Value Chain Figure 73. Wearable Neuromodulation Devices Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Wearable Neuromodulation Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Head-mounted
  • Ear-mounted
  • Arm-mounted
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Brainco
  • NeuroSky
  • Muse
  • Halo Neuroscience
  • Caputron
  • Nerivio
  • Magnus
  • Emotiv
  • Thync

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Wearable Neuromodulation Devices Market Size (2021-2032)
  4. 2.2.2 Global Wearable Neuromodulation Devices Sales (2021-2032)
  5. 2.2.3 Global Wearable Neuromodulation Devices Market Average Price (2021-2032)
  6. 2.3 Wearable Neuromodulation Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Head-mounted
  9. 2.3.3 Ear-mounted
  10. 2.3.4 Arm-mounted
  11. 2.3.5 Others
  12. 2.4 Wearable Neuromodulation Devices by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Adults
  15. 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Wearable Neuromodulation Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Wearable Neuromodulation Devices Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Wearable Neuromodulation Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Wearable Neuromodulation Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Wearable Neuromodulation Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Wearable Neuromodulation Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Wearable Neuromodulation Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Wearable Neuromodulation Devices, Established Date
  9. 3.9 Global Wearable Neuromodulation Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Brainco
  2. 4.1.1 Brainco Company Information
  3. 4.1.2 Brainco Business Overview
  4. 4.1.3 Brainco Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Brainco Wearable Neuromodulation Devices Product Portfolio
  6. 4.1.5 Brainco Recent Developments
  7. 4.2 NeuroSky
  8. 4.2.1 NeuroSky Company Information
  9. 4.2.2 NeuroSky Business Overview
  10. 4.2.3 NeuroSky Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 NeuroSky Wearable Neuromodulation Devices Product Portfolio
  12. 4.2.5 NeuroSky Recent Developments
  13. 4.3 Muse
  14. 4.3.1 Muse Company Information
  15. 4.3.2 Muse Business Overview
  16. 4.3.3 Muse Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Muse Wearable Neuromodulation Devices Product Portfolio
  18. 4.3.5 Muse Recent Developments
  19. 4.4 Halo Neuroscience
  20. 4.4.1 Halo Neuroscience Company Information
  21. 4.4.2 Halo Neuroscience Business Overview
  22. 4.4.3 Halo Neuroscience Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio
  24. 4.4.5 Halo Neuroscience Recent Developments
  25. 4.5 Caputron
  26. 4.5.1 Caputron Company Information
  27. 4.5.2 Caputron Business Overview
  28. 4.5.3 Caputron Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Caputron Wearable Neuromodulation Devices Product Portfolio
  30. 4.5.5 Caputron Recent Developments
  31. 4.6 Nerivio
  32. 4.6.1 Nerivio Company Information
  33. 4.6.2 Nerivio Business Overview
  34. 4.6.3 Nerivio Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Nerivio Wearable Neuromodulation Devices Product Portfolio
  36. 4.6.5 Nerivio Recent Developments
  37. 4.7 Magnus
  38. 4.7.1 Magnus Company Information
  39. 4.7.2 Magnus Business Overview
  40. 4.7.3 Magnus Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Magnus Wearable Neuromodulation Devices Product Portfolio
  42. 4.7.5 Magnus Recent Developments
  43. 4.8 Emotiv
  44. 4.8.1 Emotiv Company Information
  45. 4.8.2 Emotiv Business Overview
  46. 4.8.3 Emotiv Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Emotiv Wearable Neuromodulation Devices Product Portfolio
  48. 4.8.5 Emotiv Recent Developments
  49. 4.9 Thync
  50. 4.9.1 Thync Company Information
  51. 4.9.2 Thync Business Overview
  52. 4.9.3 Thync Wearable Neuromodulation Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Thync Wearable Neuromodulation Devices Product Portfolio
  54. 4.9.5 Thync Recent Developments
5 Global Wearable Neuromodulation Devices Market Scenario by Region
  1. 5.1 Global Wearable Neuromodulation Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Wearable Neuromodulation Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Wearable Neuromodulation Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Wearable Neuromodulation Devices Sales by Region: 2027-2032
  5. 5.3 Global Wearable Neuromodulation Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Wearable Neuromodulation Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Wearable Neuromodulation Devices Revenue by Region: 2027-2032
  8. 5.4 North America Wearable Neuromodulation Devices Market Facts & Figures by Country
  9. 5.4.1 North America Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Wearable Neuromodulation Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Wearable Neuromodulation Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Wearable Neuromodulation Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Wearable Neuromodulation Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Wearable Neuromodulation Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Wearable Neuromodulation Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Wearable Neuromodulation Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Wearable Neuromodulation Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Wearable Neuromodulation Devices Market Facts & Figures by Country
  41. 5.7.1 South America Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Wearable Neuromodulation Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Wearable Neuromodulation Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Wearable Neuromodulation Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Wearable Neuromodulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Wearable Neuromodulation Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Wearable Neuromodulation Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Wearable Neuromodulation Devices Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Wearable Neuromodulation Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Wearable Neuromodulation Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Wearable Neuromodulation Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Wearable Neuromodulation Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Wearable Neuromodulation Devices Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Wearable Neuromodulation Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Wearable Neuromodulation Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Wearable Neuromodulation Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Wearable Neuromodulation Devices Value Chain Analysis
  2. 8.1.1 Wearable Neuromodulation Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Wearable Neuromodulation Devices Production Mode & Process
  5. 8.2 Wearable Neuromodulation Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Wearable Neuromodulation Devices Distributors
  8. 8.2.3 Wearable Neuromodulation Devices Customers
9 Global Wearable Neuromodulation Devices Analyzing Market Dynamics
  1. 9.1 Wearable Neuromodulation Devices Industry Trends
  2. 9.2 Wearable Neuromodulation Devices Industry Drivers
  3. 9.3 Wearable Neuromodulation Devices Industry Opportunities and Challenges
  4. 9.4 Wearable Neuromodulation Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research